Tower Research Capital (TRC)’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,948
Closed -$9.75K 6171
2024
Q1
$9.75K Buy
1,948
+1,339
+220% +$6.7K ﹤0.01% 3798
2023
Q4
$4.11K Buy
609
+59
+11% +$398 ﹤0.01% 4991
2023
Q3
$5.03K Buy
550
+22
+4% +$201 ﹤0.01% 4774
2023
Q2
$11.2K Sell
528
-22
-4% -$465 ﹤0.01% 3984
2023
Q1
$15K Buy
550
+291
+112% +$7.94K ﹤0.01% 3844
2022
Q4
$9K Buy
259
+150
+138% +$5.21K ﹤0.01% 4315
2022
Q3
$25K Sell
109
-40
-27% -$9.17K ﹤0.01% 3777
2022
Q2
$28K Sell
149
-81
-35% -$15.2K ﹤0.01% 3462
2022
Q1
$58K Sell
230
-703
-75% -$177K ﹤0.01% 2616
2021
Q4
$145K Buy
933
+45
+5% +$6.99K ﹤0.01% 1990
2021
Q3
$178K Buy
888
+815
+1,116% +$163K ﹤0.01% 1923
2021
Q2
$19K Buy
73
+21
+40% +$5.47K ﹤0.01% 3960
2021
Q1
$14K Sell
52
-16
-24% -$4.31K ﹤0.01% 4174
2020
Q4
$25K Sell
68
-609
-90% -$224K ﹤0.01% 3738
2020
Q3
$165K Buy
677
+546
+417% +$133K ﹤0.01% 2750
2020
Q2
$37K Buy
131
+129
+6,450% +$36.4K ﹤0.01% 3289
2020
Q1
$0 Buy
+2
New ﹤0.01% 4114
2019
Q4
Sell
-18
Closed -$5K 4566
2019
Q3
$5K Sell
18
-145
-89% -$40.3K ﹤0.01% 3355
2019
Q2
$52K Buy
163
+154
+1,711% +$49.1K ﹤0.01% 1555
2019
Q1
$4K Sell
9
-101
-92% -$44.9K ﹤0.01% 3222
2018
Q4
$33K Buy
110
+55
+100% +$16.5K ﹤0.01% 1586
2018
Q3
$20K Buy
55
+47
+588% +$17.1K ﹤0.01% 2360
2018
Q2
$3K Buy
+8
New +$3K ﹤0.01% 3267
2018
Q1
Sell
-186
Closed -$77K 4037
2017
Q4
$77K Buy
+186
New +$77K 0.01% 1039
2017
Q3
Sell
-5
Closed -$1K 4334
2017
Q2
$1K Sell
5
-36
-88% -$7.2K ﹤0.01% 2531
2017
Q1
$14K Buy
+41
New +$14K ﹤0.01% 1568
2016
Q4
Sell
-5
Closed -$2K 4529
2016
Q3
$2K Buy
+5
New +$2K ﹤0.01% 3164
2016
Q2
Sell
-3
Closed -$1K 5116
2016
Q1
$1K Sell
3
-28
-90% -$9.33K ﹤0.01% 3831
2015
Q4
$20K Hold
31
﹤0.01% 1306
2015
Q3
$14K Buy
31
+6
+24% +$2.71K ﹤0.01% 2052
2015
Q2
$14K Buy
25
+18
+257% +$10.1K ﹤0.01% 2421
2015
Q1
$57K Buy
+7
New +$57K 0.01% 1370
2014
Q4
Hold
0
-$1K 4849
2014
Q3
Sell
-1
Closed -$8K 4187
2014
Q2
$8K Sell
1
-5
-83% -$40K ﹤0.01% 2552
2014
Q1
$33K Buy
+6
New +$33K ﹤0.01% 1420